DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs
DARPA-SN-26-77 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued Special Notice DARPA-SN-26-77 to announce forthcoming areas of interest for the Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. As part of DARPA’s broader mission to accelerate breakthrough technologies for national security, this initiative aims to address one of
DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs Read More »